PMS2 and Lynch syndrome: Compared to pathogenic variants in other MMR genes, PMS2-associated Lynch syndrome shows lower cancer susceptibility, with circa 10–13% lifetime risks for colorectal and endometrial cancer and relatively low incidence of other associated malignancies [70, 71].